LBRXLB PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of LB PHARMACEUTICALS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBRXEsta | $1.4B#7 | 1.8x#1 | 4.1x#7 | — | — | 60.1%#4 | — | -7.6%#4 | — | — | 157.7%#3 | — |
| XERS | $1.5B#1 | — | — | 5.1x#5 | 43.7%#1 | 101.0%#1 | 8.5%#3 | — | 20.6%#2 | — | 6.5%#7 | — |
| TYRA | $1.5B#2 | — | 4.1x#8 | — | — | -38.7%#8 | — | -33.9%#7 | — | — | 101.1%#4 | — |
| RARE | $1.4B#3 | — | — | 2.1x#2 | 20.2%#4 | -1.1%#5 | -79.5%#5 | — | — | — | -49.5%#10 | — |
| DMRA | $1.4B#4 | 3.0x#2 | 2.7x#3 | — | — | -878.8%#12 | — | -40.7%#9 | — | — | 675.3%#1 | — |
| TRAX | $1.4B#5 | — | 8.3x#10 | — | — | — | — | 0.0%#1 | — | — | — | — |
| AVBP | $1.4B#6 | — | 3.8x#6 | — | — | -106.6%#10 | — | -45.3%#10 | — | — | 62.0%#5 | — |
| OMER | $1.3B#8 | 10.7x#3 | — | 18.1x#6 | -34.0%#6 | 97.9%#2 | -166.4%#6 | — | -151.8%#6 | — | 353.6%#2 | — |
| ORIC | $1.3B#9 | — | 3.5x#5 | — | — | -1.3%#6 | — | -34.0%#8 | -40.4%#5 | — | 22.6%#6 | — |
| HROW | $1.2B#10 | — | 81.8x#11 | 4.6x#4 | 36.4%#2 | 70.6%#3 | 11.2%#1 | -33.8%#6 | 13.2%#3 | 6#1 | -23.1%#8 | — |
| AKTS | $1.2B#11 | — | 2.5x#2 | — | — | — | — | 0.0%#1 | — | — | — | — |
| ANRO | $1.2B#12 | — | 5.5x#9 | — | — | -2.9%#7 | — | -28.8%#5 | — | — | — | — |
| OPK | $1.2B#13 | — | 1.0x#1 | 2.0x#1 | -14.9%#5 | -324.0%#11 | -19.3%#4 | -19058.1%#11 | -13.3%#4 | 4#2 | — | — |
| SPTX | $1.2B#14 | — | 2.8x#4 | — | — | — | — | 0.0%#1 | — | — | — | — |
| MNKD | $1.2B#15 | — | — | 3.3x#3 | 22.2%#3 | -78.7%#9 | 11.1%#2 | — | 2283.8%#1 | — | -33.5%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice